Indeed, the LeuRS-RagD inhibitor BC-LI-0186 is effective in restoring autophagy and muscle strength in dystrophic mice, which provides the first proof of principle for therapeutic targeting of the noncanonical function of a housekeeping protein in the potential treatment of DMD. The gene discussed is RRAGD; the disease is Duchenne muscular dystrophy.